Literature DB >> 28296656

Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic Insults: Analysis of 368 Patients.

Saurabh Kedia, Soumya J Mahapatra, Baibaswata Nayak, Deepak Gunjan, Bhaskar Thakur, Subrat K Acharya.   

Abstract

BACKGROUND: Acute-on-chronic liver failure (ACLF) may be precipitated by various hepatic insults. The present study evaluated the outcomes of ACLF with different acute insults. PATIENTS AND METHODS: A total of 368 ACLF patients were included. Data collected included etiologies of acute hepatic insult and underlying chronic liver disease, and organ failure. Model for end-stage liver disease (MELD), chronic liver failure consortium (CLIF)-C ACLF, and acute physiology and chronic health evaluation (APACHE) II scores were calculated. Predictors of survival were assessed by the Cox proportional hazard model.
RESULTS: The most frequent acute insult was active alcohol consumption [150 (40.8%) patients], followed by hepatitis B virus (HBV) [71 (19.3%) patients], hepatitis E virus (HEV) superinfection [45 (12.2%) patients], autoimmune hepatitis flare [17 (4.6%) patients], antituberculosis drugs [16 (4.3%) patients], and hepatitis A virus superinfection [2 (0.5%) patients]; 67 (18.2%) cases were cryptogenic. Alcohol-ACLF and cryptogenic-ACLF were more severe. Median CLIF-C, MELD, and APACHE II scores in alcohol-ACLF and cryptogenic-ACLF were significantly higher than those in HBV-ACLF and HEV-ACLF (CLIF-C: 47.1, 47.4 vs. 42.9, 42.0, P=0.002; MELD: 29, 29.9 vs. 28.9, 25.2, P=0.02; APACHE II: 16.5, 18.0 vs. 12, 14, P<0.001, respectively). Frequencies of kidney and brain failures were also higher in alcohol/cryptogenic-ACLF than in HBV/HEV-ACLF (kidney failure: 35.3%/34.3% vs. 23.9%/11.1%, P=0.009; brain failure: 26.0%/22.4% vs. 15.5%/4.4%, P=0.01, respectively). Mortality in the alcohol-ACLF group was the highest (64.0%), followed by that in the cryptogenic-ACLF (62.7%), HBV-ACLF (45.1%), and HEV-ACLF (17.8%) groups (P<0.001). In multivariable analysis, alcohol-ACLF had significantly higher mortality compared with HEV-ACLF (hazard ratio, 3.06; 95% confidence interval, 1.10-8.49, P=0.03).
CONCLUSIONS: Alcohol/cryptogenic-ACLF had more severe phenotypic presentation, more incidence of organ failures, and higher mortality compared with HEV/HBV-ACLF. Alcohol-ACLF had the highest mortality, whereas HEV-ACLF had the best survival.

Entities:  

Mesh:

Year:  2017        PMID: 28296656     DOI: 10.1097/MCG.0000000000000823

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

1.  Spectrum of Neuroimaging Abnormalities in Brain in Patients of Acute-on-Chronic Liver Failure.

Authors:  Shekhar S Jadaun; Sanchit Sharma; Kumble S Madhusudhan; Raju Sharma; Baibaswata Nayak; Saurabh Kedia; Vishwajeet Singh; Deepak Gunjan; Subrat K Acharya; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

Review 2.  Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure.

Authors:  Chong Chen; Shu-Ye Zhang; Liang Chen
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

3.  Alcohol-related acute-on-chronic liver failure-Comparison of various prognostic scores in predicting outcome.

Authors:  Ujjwal Sonika; Shekhar Jadaun; Gyan Ranjan; Gyanranjan Rout; Deepak Gunjan; Saurabh Kedia; Baibaswata Nayak
Journal:  Indian J Gastroenterol       Date:  2018-02-23

4.  Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.

Authors:  Sanchit Sharma; Samagra Agarwal; Srikant Gopi; Abhinav Anand; Srikant Mohta; Deepak Gunjan; Rajni Yadav; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2020-08-22

Review 5.  The Clinical Perspective on Hepatitis E.

Authors:  Thomas Horvatits; Julian Schulze Zur Wiesch; Marc Lütgehetmann; Ansgar W Lohse; Sven Pischke
Journal:  Viruses       Date:  2019-07-05       Impact factor: 5.048

6.  Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.

Authors:  Hitomi Hoshi; Po-Sung Chu; Aya Yoshida; Nobuhito Taniki; Rei Morikawa; Karin Yamataka; Fumie Noguchi; Ryosuke Kasuga; Takaya Tabuchi; Hirotoshi Ebinuma; Hidetsugu Saito; Takanori Kanai; Nobuhiro Nakamoto
Journal:  PLoS One       Date:  2021-04-13       Impact factor: 3.240

7.  Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019.

Authors:  Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Abhinav Anand; Deepak Gunjan; Saurabh Kedia; Soumya J Mahapatra; Baibaswata Nayak; Sabreena Sheikh; Kapil D Soni; Anjan Trikha; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-10-29

8.  Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.

Authors:  Xiaoping Wang; Mengying Sun; Xianjun Yang; Liucun Gao; Min Weng; Dehui Yang; Hongyong Li; Xiaolei Zhou; Jiani Li; Sen Qin; Dejiang Zhou; Xiaoling Wu; Shanhong Tang; Weizheng Zeng
Journal:  Biomed Res Int       Date:  2020-08-06       Impact factor: 3.411

9.  Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis.

Authors:  Yu-Pei Zhuang; Si-Qi Wang; Zhao-Yu Pan; Hao-Jie Zhong; Xing-Xiang He
Journal:  Open Med (Wars)       Date:  2021-12-06

10.  Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.

Authors:  Anshuman Elhence; Manas Vaishnav; Ramesh Kumar; Piyush Pathak; Kapil Dev Soni; Richa Aggarwal; Manish Soneja; Pankaj Jorwal; Arvind Kumar; Puneet Khanna; Akhil Kant Singh; Ashutosh Biswas; Neeraj Nischal; Lalit Dar; Aashish Choudhary; Krithika Rangarajan; Anant Mohan; Pragyan Acharya; Baibaswata Nayak; Deepak Gunjan; Anoop Saraya; Soumya Mahapatra; Govind Makharia; Anjan Trikha; Pramod Garg
Journal:  Indian J Gastroenterol       Date:  2020-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.